Case-based lecture : Novel agents in relapsed multiple myeloma (Selinexor, Belantamab, Venetoclax, etc)
ESH eLearning, Michel Delforge,
382666
Selected brief oral communication: Novel, potent, compact, erythroid specific enhancers successfully replace the beta globin-uLCR in gene therapy vectors for beta hemoglobinopathies
ESH eLearning, Kiriaki Paschoudi,
376424